Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Holmes

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
The Oncologist|March 9, 2021
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial CarcinomasRichard S P Huang, James Haberberger, Lukas Harries, et al.
The Oncologist|February 18, 2017
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase FusionsPierre Vanden Borre, Alexa B Schrock, Peter M Anderson, et al.
BMC Medical Genomics|February 6, 2019
Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samplesFelicity Newell, Kalpana Patel, Michael Gartside, et al.
Oncology|October 21, 2016
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 FusionVivek Subbiah, Oliver Holmes, Kyle Gowen, et al.
Plos One|October 11, 2012
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profilesSarah Song, Katia Nones, David Miller, et al.
Plos One|January 11, 2018
Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencingAnn-Marie Patch, Katia Nones, Stephen H Kazakoff, et al.
Nucleic Acids Research|May 3, 2018
Telomere sequence content can be used to determine ALT activity in tumoursMichael Lee, Erdahl T Teber, Oliver Holmes, et al.
Pathology Oncology Research : POR|July 14, 2021
Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 ImmunohistochemistryRichard S P Huang, Eric Severson, James Haberberger, et al.
The Oncologist|September 2, 2020
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast CancerRichard S P Huang, Xinyan Li, James Haberberger, et al.
Cancers|February 24, 2024
Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel SequencingDavid Fielding, Vanessa Lakis, Andrew J Dalley, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
The Oncologist|March 9, 2021
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial CarcinomasRichard S P Huang, James Haberberger, Lukas Harries, et al.
The Oncologist|February 18, 2017
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase FusionsPierre Vanden Borre, Alexa B Schrock, Peter M Anderson, et al.
BMC Medical Genomics|February 6, 2019
Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samplesFelicity Newell, Kalpana Patel, Michael Gartside, et al.
Oncology|October 21, 2016
Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 FusionVivek Subbiah, Oliver Holmes, Kyle Gowen, et al.
Plos One|October 11, 2012
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profilesSarah Song, Katia Nones, David Miller, et al.
Plos One|January 11, 2018
Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencingAnn-Marie Patch, Katia Nones, Stephen H Kazakoff, et al.
Nucleic Acids Research|May 3, 2018
Telomere sequence content can be used to determine ALT activity in tumoursMichael Lee, Erdahl T Teber, Oliver Holmes, et al.
Pathology Oncology Research : POR|July 14, 2021
Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 ImmunohistochemistryRichard S P Huang, Eric Severson, James Haberberger, et al.
The Oncologist|September 2, 2020
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast CancerRichard S P Huang, Xinyan Li, James Haberberger, et al.
Cancers|February 24, 2024
Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel SequencingDavid Fielding, Vanessa Lakis, Andrew J Dalley, et al.
Pageof 6